封面
市場調查報告書
商品編碼
1731516

乳糖酶市場成長、規模和趨勢分析(按來源、用途和形式)—區域展望、競爭策略和細分預測(至 2034 年)

Lactase Market Growth, Size, Trends Analysis - By Source, By Application, By Form - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 256 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年全球乳糖酶市場規模將達到 4.0358 億美元,預測期內複合年成長率為 5.33%。

乳糖酶是存在於人類和其他動物胃中的一種酶,它將乳糖分解為葡萄糖和半乳糖。乳製品中含有乳糖,乳糖酶有助於分解乳糖。某些人缺乏乳糖酶,因此無法消化乳製品中的乳糖。為了解決這個問題,人們在乳製品中添加乳糖酶或服用乳糖酶補充劑,這有助於在食用之前分解乳糖。

本報告調查了全球乳糖酶市場,並提供了市場概況摘要、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場、地區/主要國家的詳細分析、競爭格局以及主要企業的概況。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場動態

  • 促進因素、阻礙因素、機會與挑戰分析

第5章 市場變數與展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭態勢

  • 製造地、銷售區域、產品類型分佈
  • 併購、合作夥伴關係、產品發布和合作

7. 全球乳糖酶市場(依來源)

  • 真菌
  • 酵母菌
  • 細菌

8. 全球乳糖酶市場應用

  • 食品/飲料
    • 牛奶
    • 起司
    • 優格
    • 其他
  • 營養補充品
  • 製藥

9. 全球乳糖酶市場(依形式)

  • 粉末
  • 液體

第10章世界乳糖酶市場

  • 市場規模和市場佔有率

第 11 章全球乳糖酶市場(按地區)

  • 亞太地區
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 埃及
    • 摩洛哥
    • 奈及利亞
    • 其他
  • 北美洲
    • 加拿大
    • 墨西哥
    • 美國
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 其他

第12章 公司簡介

  • Mitushi Biopharma
  • Rajvi Enterprise
  • Infinita Biotech Pvt. Ltd
  • Aumgene Biosciences
  • DuPont
  • Antozyme Biotech Pvt. Ltd
  • Novact Corp
  • Biolaxi Corp
  • Creative Enzymes
  • Nature BioScience Pvt. Ltd
  • ENMEX
  • Advanced Enzyme Technologies
  • Amano Enzyme Inc
  • Senson
  • Merck KGaA
  • 其他

第13章結論

第 14 章簡稱列表

第 15 章參考鏈接

簡介目錄
Product Code: FOOD2548

Lactase Market Introduction and Overview

According to SPER market research, 'Global Lactase Market Size- By Source, By Application, By Form - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Lactase Market is predicted to reach 403.58 million by 2034 with a CAGR of 5.33%.

Lactase is an enzyme present in the stomachs of humans and other animals that splits lactose into glucose and galactose. Lactose is found in milk products, and lactase aids in its breakdown. Some populations are unable to digest the lactose found in milk products due to a lack of lactase enzymes. To address this issue, lactase is added to dairy products or lactase supplements are supplied so that lactose can be broken down before to intake.

Restraints: Many people are lactose intolerant, which prevents them from drinking milk and dairy products. Lactose-free milk is available, however it is more expensive than regular milk. There have been several ways studied for lowering lactose in milk and dairy products. Lactose-free products are more expensive because the lactose hydrolysis process adds costs. Small and medium-sized enterprises can efficiently manage costs despite a lack of resources and capital, as well as implementation experience.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Source, By Application, By Form.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered Mitushi Biopharma, Rajvi Enterprise, Infinita Biotech Private Limited, Aumgene Biosciences, DuPont, Antozyme Biotech Pvt Ltd, Novact Corporation, Biolaxi Corporation, Creative Enzymes, Nature BioScience Pvt. L.T.D, ENMEX, Advanced Enzyme Technologies, Amano Enzyme Inc, Senson, Merck KGaA.

Lactase Market Segmentation:

By Source: Based on the Source, Global Lactase Market is segmented as; Fungi, Yeast, Bacteria.

By Application: Based on the Application, Global Lactase Market is segmented as; Food & Beverages, Dietary Supplements, Pharmaceuticals.

By Form: Based on the Form, Global Lactase Market is segmented as; Powder, Liquid.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPERs internal database
    • 2.1.4. Premium insight from KOLs
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTERs Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Lactase Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Lactase Market

7. Global Lactase Market, By Source (USD Million) 2021-2034

  • 7.1. Fungi
  • 7.2. Yeast
  • 7.3. Bacteria

8. Global Lactase Market, By Application (USD Million) 2021-2034

  • 8.1. Food & Beverages
    • 8.1.1. Milk
    • 8.1.2. Cheese
    • 8.1.3. Yogurt
    • 8.1.4. Others
  • 8.2. Dietary Supplements
  • 8.3. Pharmaceuticals

9. Global Lactase Market, By Form (USD Million) 2021-2034

  • 9.1. Powder
  • 9.2. Liquid

10. Global Lactase Market, (USD Million) 2021-2034

  • 10.1. Global Lactase Market Size and Market Share

11. Global Lactase Market, By Region, (USD Million) 2021-2034

  • 11.1. Asia-Pacific
    • 11.1.1. Australia
    • 11.1.2. China
    • 11.1.3. India
    • 11.1.4. Japan
    • 11.1.5. South Korea
    • 11.1.6. Rest of Asia-Pacific
  • 11.2. Europe
    • 11.2.1. France
    • 11.2.2. Germany
    • 11.2.3. Italy
    • 11.2.4. Spain
    • 11.2.5. United Kingdom
    • 11.2.6. Rest of Europe
  • 11.3. Middle East and Africa
    • 11.3.1. Kingdom of Saudi Arabia
    • 11.3.2. United Arab Emirates
    • 11.3.3. Qatar
    • 11.3.4. South Africa
    • 11.3.5. Egypt
    • 11.3.6. Morocco
    • 11.3.7. Nigeria
    • 11.3.8. Rest of Middle-East and Africa
  • 11.4. North America
    • 11.4.1. Canada
    • 11.4.2. Mexico
    • 11.4.3. United States
  • 11.5. Latin America
    • 11.5.1. Argentina
    • 11.5.2. Brazil
    • 11.5.3. Rest of Latin America

12. Company Profile

  • 12.1. Mitushi Biopharma
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. Rajvi Enterprise
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. Infinita Biotech Pvt. Ltd
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. Aumgene Biosciences
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. DuPont
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. Antozyme Biotech Pvt. Ltd
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. Novact Corp
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. Biolaxi Corp
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. Creative Enzymes
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10. Nature BioScience Pvt. Ltd
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11. ENMEX
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12. Advanced Enzyme Technologies
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13. Amano Enzyme Inc
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14. Senson
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15. Merck KGaA
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16. Others

13. Conclusion

14. List of Abbreviations

15. Reference Links